In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 


The free consultation period for this content is over.

It is now only available year-round to EACVI Silver Members, Fellows of the ESC and Young combined Members

Cardiac Computed Tomography as first-line test for coronary disease: nice, but wise ? - CONTRA.

Session Controversies in imaging coronary artery disease

Speaker Leslee Shaw

Congress : EuroEcho-Imaging 2018

  • Topic : imaging
  • Sub-topic : Cross-Modality and Multi-Modality Imaging, Other
  • Session type : Debate Session
  • FP Number : 999

The free consultation period for this content is over.

It is now only available year-round to EACVI Silver Members, Fellows of the ESC and Young combined Members

Other presentations from this session

Controversies in imaging coronary artery disease

  • EuroEcho-Imaging 2018
  • Cross-Modality and Multi-Modality Imaging, Other
  • Debate Session
  • 07 December 2018
  • 08:30 - 10:00
session 2018 2018
12

Other presentations from this speaker

no speaker photo speaker

Leslee Shaw

11


Based on your interests

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are